Every material Form 8-K IMAX CORP has filed with the SEC since July 23, 2026, read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). Newest first; each brief links to its own page and to the filing on SEC.gov.
IMAX reported third-quarter 2026 revenue of $174.6 million, up 64% from a year earlier, and net income of $117.1 million, or $1.96 per diluted share, compared with $0.37 a year earlier. Net income includes a $36.7 million ($0.63 per diluted share) tax valuation allowance release, so part of the profit increase comes from a one-time tax benefit rather than operations alone.
Revenue of $174.6 million, up 64% from $106.7 million; gross margin of $126.3 million, a 72.3% margin
Net income attributable to common shareholders of $113.8 million; diluted EPS of $1.96 versus $0.37
Includes $36.7 million ($0.63 per diluted share) valuation allowance release on Canadian deferred tax assets
Global box office of $712 million in the quarter; no share repurchases in Q3 2026 and about $237.0 million remaining under the buyback program
On August 19, 2026, IMAX amended the employment agreement of Chief Legal Officer and Senior Executive Vice President Robert D. Lister, extending its term to December 31, 2029. The filing says his other compensation and severance terms are unchanged, except for revised treatment of unvested equity awards if he leaves before or after that date. The change is administrative in nature and does not state any new pay amounts.
Amendment dated August 19, 2026 is the third amendment to Lister's agreement, originally dated December 18, 2017.
Employment agreement term extended to December 31, 2029.
If Lister resigns without Good Reason or is terminated for cause before December 31, 2029, unvested equity is cancelled, unless he gave at least six months' written notice of resignation.
The full amendment will be filed as an exhibit to the Form 10-Q for the quarter ending September 30, 2026.
IMAX reported second quarter 2026 results, with revenue of $102.8 million, up 12% from a year earlier, and net income attributable to common shareholders of $15.4 million, up 36%. The company said it beat consensus estimates and pointed to the opening of Christopher Nolan's The Odyssey, though the filing gives no updated full-year guidance. For shareholders, the quarter shows higher revenue and profit, with GAAP diluted earnings per share up 35% to $0.27.
Revenue was $102.8 million versus $91.7 million in Q2 2025, up 12%; gross margin was 61.2%, up from 58.5%.
GAAP diluted EPS was $0.27 versus $0.20; company-defined adjusted diluted EPS was $0.43 versus $0.26.
The company repurchased 404,866 shares for $13.7 million in Q2 2026, with about $237.0 million left under its $500.0 million authorization.
As of June 30, 2026, available liquidity was $551 million and total debt was $292 million.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Only material 8-Ks get a brief: results, deals, executive changes, restructuring, impairments, delisting notices, restatements, cybersecurity incidents and other disclosed events. Routine filings (vote results, exhibits only) are skipped. Every IMAX CORP filing is on SEC EDGAR ↗. 8-K briefs of other companies →